The mRNAs F11, FBP1, and SLC6A13 were associated with the good prognosis of the HBV-related HCC patients in the training cohort (Supplementary Figures 2B–D) and test cohort (Supplementary Figures 3B–D). Here, F11 is linked to hepatocellular carcinoma.